Long-term Intraocular Pressure Fluctuations and Risk of Conversion from Ocular Hypertension to Glaucoma

Ophthalmology

Volumn 115, Issue 6, 2008, Pages 934-940

  Medeiros, Felipe A ^a   Weinreb, Robert N ^a   Zangwill, Linda M ^a   Alencar, Luciana M ^a   Sample, Pamela A ^a   Vasile, Cristiana ^a   Bowd, Christopher ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; OPTIC DISK; PERIMETRY; PRIORITY JOURNAL; RISK FACTOR; STEREOPHOTOGRAMMETRY; VISUAL FIELD;

COHORT STUDIES; CONFIDENCE INTERVALS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPTIC DISK; OPTIC NERVE DISEASES; PERIMETRY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 44349113431     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.08.012     Document Type: Article

References (22)

1. Leske M.C., Heijl A., Hussein M., et al., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
2. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30.
3. Lichter P.R., Musch D.C., Gillespie B.W., et al., CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
4. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
5. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
6. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9 (2000) 134-142
7. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
8. Bergea B., Bodin L., and Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 106 (1999) 997-1004 discussion 1004-5.
9. Gonzalez I., Pablo L.E., Pueyo M., et al. Assessment of diurnal tensional curve in early glaucoma damage. Int Ophthalmol 1996- 20 (1997) 113-115
10. Bengtsson B., Leske M.C., Hyman L., Heijl A., and Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 114 (2007) 205-209
11. Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 829-30.
12. European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 3-9
13. Keltner J.L., Johnson C.A., Quigg J.M., et al. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 118 (2000) 1187-1194
14. Medeiros F.A., Sample P.A., Zangwill L.M., et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 136 (2003) 805-813
15. Lin D.Y., and Wei L.J. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84 (1989) 1074-1078
16. Bengtsson B., and Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 243 (2005) 513-518
17. Liu J.H., Zhang X., Kripke D.F., and Weinreb R.N. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 44 (2003) 1586-1590
18. Medeiros F.A., Weinreb R.N., Sample P.A., et al. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol 123 (2005) 1351-1360
19. Ocular Hypertension Treatment Study Group, and European Glaucoma Prevention Study Group. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114 (2007) 10-19
20. Mansberger S.L. A risk calculator to determine the probability of glaucoma. J Glaucoma 13 (2004) 345-347
21. Karp I., Abrahamowicz M., Bartlett G., and Pilote L. Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol 160 (2004) 707-716
22. D'Agostino R.B., Russell M.W., Huse D.M., et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 139 (2000) 272-281